Sublethal Hepatic Pathology and Evidence of Intranuclear Effects of the Cyanobacterial Toxin Microcystin -Lr
Guzman, Roberto Enrique
This item is only available for download by members of the University of Illinois community. Students, faculty, and staff at the U of I may log in with your NetID and password to view the item. If you are trying to access an Illinois-restricted dissertation or thesis, you can request a copy through your library's Inter-Library Loan office or purchase a copy directly from ProQuest.
Permalink
https://hdl.handle.net/2142/87619
Description
Title
Sublethal Hepatic Pathology and Evidence of Intranuclear Effects of the Cyanobacterial Toxin Microcystin -Lr
Author(s)
Guzman, Roberto Enrique
Issue Date
2001
Doctoral Committee Chair(s)
Philip Solter
Department of Study
Veterinary Pathobiology
Discipline
Veterinary Pathobiology
Degree Granting Institution
University of Illinois at Urbana-Champaign
Degree Name
Ph.D.
Degree Level
Dissertation
Keyword(s)
Health Sciences, Pathology
Language
eng
Abstract
Microcystin-LR (MCLR) is a hepatotoxin and phosphatase inhibitor produced by Microcystis aeruginosa. The pathology of sublethal exposure is not well characterized. MCLR immunohistochemistry (MCLR-IHC) studies indicate that the nucleus may be a target of MCLR. Balb/c mice were given one sublethal dose at 45 mug/kg or repeated daily doses for 2, 4 and 7 days. At 2 hours post-dosing there was centrilobular hepatocellular hypertrophy, glycogen depletion, apoptosis and eosinophilic cytoplasmic condensation. Repeated dosing induced hepatocytomegaly and karyomegaly with multinucleation. Hepatocyte nuclei were strongly labeled by MCLR-IHC, 4 hours after one sublethal dose. Western blotting confirmed the presence of toxin in the nucleus bound to protein phosphatases 1 and 2A. Nuclear phosphatase activity of mice given an acutely lethal dose was profoundly inhibited. Nuclear phosphatase activity was unchanged in mice given sublethal doses despite detection of MCLR by ELISA. Using phosphoserine specific antibodies it was shown that MCLR exposure increases the phosphorylation of p53. I postulated that MCLR-induced hepatocyte apoptosis was a p53 dependent event involving postranslational phosphorylation. Mice homozygous for a defective p53 gene and mice with normal p53 were given doses of MCLR. Also, pifithrin, a chemical inhibitor of p53, was used to determine if it could prevent MCLR induced hepatocyte apoptosis. In both experiments, p53 did not play an essential role in the induction of apoptosis, indicating that other pathways are involved. Mice given a similar daily sublethal dose for 7 days, had decreased amounts of p53 after challenge with a DNA-damaging agent. It was concluded that sublethal doses of MCLR induce hepatic lesions that in conjunction with MCLR-IHC could assist in the diagnosis of field cases. MCLR accumulates in the hepatocyte nucleus, an event that results in increased phosphorylation of p53, but other pathways are likely involved in the execution of hepatocyte apoptosis after MCLR exposure. Reduced production of this tumor suppressor protein induced by prolonged exposure to MCLR would favor the formation of hepatic neoplasia.
Use this login method if you
don't
have an
@illinois.edu
email address.
(Oops, I do have one)
IDEALS migrated to a new platform on June 23, 2022. If you created
your account prior to this date, you will have to reset your password
using the forgot-password link below.
